These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

794 related items for PubMed ID: 29127512

  • 1. Surgical management of spinal solitary fibrous tumor/hemangiopericytoma: a case series of 20 patients.
    Jia Q, Zhou Z, Zhang D, Yang J, Liu C, Wang T, Wu Z, Yang C, Wei H, Zhao J, Liu T, Zhou W, Yang X, Xiao J.
    Eur Spine J; 2018 Apr; 27(4):891-901. PubMed ID: 29127512
    [Abstract] [Full Text] [Related]

  • 2. A review of solitary fibrous tumor/hemangiopericytoma tumor and a comparison of risk factors for recurrence, metastases, and death among patients with spinal and intracranial tumors.
    Giordan E, Marton E, Wennberg AM, Guerriero A, Canova G.
    Neurosurg Rev; 2021 Jun; 44(3):1299-1312. PubMed ID: 32556679
    [Abstract] [Full Text] [Related]

  • 3. Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system.
    Boyett D, Kinslow CJ, Bruce SS, Sonabend AM, Rae AI, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Wang TJC.
    J Neurooncol; 2019 Jul; 143(3):457-464. PubMed ID: 31054100
    [Abstract] [Full Text] [Related]

  • 4. Solitary Fibrous Tumor/Hemangiopericytoma of Spinal Cord: A Retrospective Single-Center Study of 16 Cases.
    Wang J, Zhao K, Han L, Jiao L, Liu W, Xu Y, Niu H, Ke C, Shu K, Lei T.
    World Neurosurg; 2019 Mar; 123():e629-e638. PubMed ID: 30554000
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of intracranial solitary fibrous tumor and hemangiopericytoma: analysis according to the 2016 WHO classification of central nervous system tumors.
    Kim BS, Kim Y, Kong DS, Nam DH, Lee JI, Suh YL, Seol HJ.
    J Neurosurg; 2018 Dec 01; 129(6):1384-1396. PubMed ID: 29372881
    [Abstract] [Full Text] [Related]

  • 6. Analyses of prognosis-related factors of intracranial solitary fibrous tumors and hemangiopericytomas help understand the relationship between the two sorts of tumors.
    Zeng L, Wang Y, Wang Y, Han L, Niu H, Zhang M, Ke C, Chen J, Lei T.
    J Neurooncol; 2017 Jan 01; 131(1):153-161. PubMed ID: 27671018
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcomes in central nervous system solitary-fibrous tumor/hemangiopericytoma: a STROBE-compliant single-center analysis.
    Yu Y, Hu Y, Lv L, Chen C, Yin S, Jiang S, Zhou P.
    World J Surg Oncol; 2022 May 10; 20(1):149. PubMed ID: 35538540
    [Abstract] [Full Text] [Related]

  • 8. Meningeal solitary fibrous tumor/hemangiopericytoma: Emphasizing on STAT 6 immunohistochemistry with a review of literature.
    Ahmad Z, Tariq MU, Din NU.
    Neurol India; 2018 May 10; 66(5):1419-1426. PubMed ID: 30233017
    [Abstract] [Full Text] [Related]

  • 9. [Solitary fibrous tumor/hemangiopericytoma of central nervous system: a clinicopathologic analysis of 71 cases].
    Li XL, Fu WW, Zhang S, Chen DY, Chen YP, Wu J, Liu XY, Li GP, Lin SM, Luo S, Cai SS, Guo W, Wang XF.
    Zhonghua Bing Li Xue Za Zhi; 2017 Jul 08; 46(7):465-470. PubMed ID: 28728219
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reappraisal of morphological and immunohistochemical spectrum of intracranial and spinal solitary fibrous tumors/hemangiopericytomas with impact on long-term follow-up.
    Shukla P, Gulwani HV, Kaur S, Shanmugasundaram D.
    Indian J Cancer; 2018 Jul 08; 55(3):214-221. PubMed ID: 30693881
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma.
    Kamamoto D, Ohara K, Kitamura Y, Yoshida K, Kawakami Y, Sasaki H.
    J Neurooncol; 2018 Sep 08; 139(2):251-259. PubMed ID: 29675794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
    Bertero L, Anfossi V, Osella-Abate S, Disanto MG, Mantovani C, Zenga F, Rudà R, Garbossa D, Soffietti R, Ricardi U, Papotti M, Cassoni P.
    PLoS One; 2018 Sep 08; 13(9):e0203570. PubMed ID: 30183767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma.
    Sagiv O, Bell D, Guo Y, Su S, Wester ST, Jiang K, Yin VT, Shinder R, Hayek B, Kim HJ, Tetzlaff MT, Esmaeli B.
    Ophthalmic Plast Reconstr Surg; 2019 Sep 08; 35(2):148-154. PubMed ID: 30371551
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.